Resultados de la búsqueda 621-630 of 18672 for Gene therapy
The primary purpose of the phase II study is to estimate the progression-free survival rate at 2 years post-registration to see if treatment is efficacious ...
This is a phase II multi-center study of nab-paclitaxel, gemcitabine and cisplatin (NGC triple regimen) as preoperative therapy in potentially resectable ...
... therapy for breast cancer. We hope to use these samples to find out why some patients still have cancer after they have completed neoadjuvant anticancer therapy ...
... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... therapy are unknown. In addition, relatively little is known about the ...
Also, to evaluate the feasibility of molecular characterization based on TMB and gene ... treatment response to targeted therapy and immunotherapy for patients ...
Healing starts here. The right answers the first time. Effective treatment depends on getting the right diagnosis. Our experts diagnose and treat the toughest ...
The purpose of this study is to to determine the individual treatment effect of somatostatin and whether duration of antibiotic therapy coupled with octreotide ...
... therapies in these preclinical models. Molecular characterization may include short tandem DNA repeat; STR) and oncogenic/tumor suppressor gene mutation ...
This study will include some patients receiving the hormone therapy and some patients who are not, so we can better understand whether patients getting the ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?